Published in Gut Microbes on January 27, 2014
A core gut microbiome in obese and lean twins. Nature (2008) 52.30
Host-bacterial mutualism in the human intestine. Science (2005) 26.39
Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med (2013) 20.65
Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol (2004) 18.85
Quorum sensing in bacteria: the LuxR-LuxI family of cell density-responsive transcriptional regulators. J Bacteriol (1994) 17.55
Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature (2008) 12.45
Reciprocal gut microbiota transplants from zebrafish and mice to germ-free recipients reveal host habitat selection. Cell (2006) 9.64
How bacteria stick. Sci Am (1978) 9.00
Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A (2010) 8.56
Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell (2013) 8.11
Functional interactions between the gut microbiota and host metabolism. Nature (2012) 7.91
Gut microbiota in health and disease. Physiol Rev (2010) 7.76
Identifying genetic determinants needed to establish a human gut symbiont in its habitat. Cell Host Microbe (2009) 6.67
Gut immune maturation depends on colonization with a host-specific microbiota. Cell (2012) 5.91
Effect of streptomycin on susceptibility of intestinal tract to experimental Salmonella infection. Proc Soc Exp Biol Med (1954) 5.91
Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice. Proc Natl Acad Sci U S A (2011) 4.85
CHANGES IN THE MOUSE'S ENTERIC MICROFLORA ASSOCIATED WITH ENHANCED SUSCEPTIBILITY TO SALMONELLA INFECTION FOLLOWING STREPTOMYCIN TREATMENT. J Infect Dis (1964) 3.75
Stool substitute transplant therapy for the eradication of Clostridium difficile infection: 'RePOOPulating' the gut. Microbiome (2013) 3.56
Burden of Clostridium difficile on the healthcare system. Clin Infect Dis (2012) 3.20
Tit-for-tat: type VI secretion system counterattack during bacterial cell-cell interactions. Cell (2013) 2.73
A mouse model for S. typhimurium-induced enterocolitis. Trends Microbiol (2005) 2.09
Probiotic bacteria reduce salmonella typhimurium intestinal colonization by competing for iron. Cell Host Microbe (2013) 2.06
Eating for two: how metabolism establishes interspecies interactions in the gut. Cell Host Microbe (2011) 2.06
Effect of streptomycin administration on colonization resistance to Salmonella typhimurium in mice. Infect Immun (1985) 1.99
Microbiota-targeted therapies: an ecological perspective. Sci Transl Med (2012) 1.80
Creating and characterizing communities of human gut microbes in gnotobiotic mice. ISME J (2010) 1.60
Consequences of Clostridium difficile infection: understanding the healthcare burden. Clin Microbiol Infect (2012) 1.33
The microbiota and allergies/asthma. PLoS Pathog (2010) 1.32
The human microbiome: ecosystem resilience and health. Nutr Rev (2012) 1.30
Intragastric infection of germfree and conventional mice with Salmonella typhimurium. Braz J Med Biol Res (1989) 1.09
The impact of antibiotics on the gut microbiota as revealed by high throughput DNA sequencing. Discov Med (2012) 1.08
Type 6 secretion system-mediated immunity to type 4 secretion system-mediated gene transfer. Science (2013) 1.03
Intestinal microbiome of poultry and its interaction with host and diet. Gut Microbes (2013) 0.98
Colonization resistance: battle of the bugs or Ménage à Trois with the host? PLoS Pathog (2013) 0.96
Clostridium difficile: Changing Epidemiology, Treatment and Infection Prevention Measures. Curr Infect Dis Rep (2012) 0.95
Microbial and metabolic interactions between the gastrointestinal tract and Clostridium difficile infection. Gut Microbes (2013) 0.94
A fresh look at the hygiene hypothesis: how intestinal microbial exposure drives immune effector responses in atopic disease. Semin Immunol (2013) 0.90
Host cell-induced signaling causes Clostridium perfringens to upregulate production of toxins important for intestinal infections. Gut Microbes (2013) 0.87
Important clinical advances in the understanding of Clostridium difficile infection. Curr Opin Gastroenterol (2013) 0.86
Interactions between the intestinal microbiota and innate lymphoid cells. Gut Microbes (2013) 0.86
Efficient responses to host and bacterial signals during Vibrio cholerae colonization. Gut Microbes (2013) 0.80
Cross-talk in the gut. Genome Biol (2009) 0.76